Cathie Wood Intellia Therapeutics, Inc. Put Options Transaction History
Ark Investment Management LLC
- $12.1 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NTLA
# of Institutions
333Shares Held
96.5MCall Options Held
1.76MPut Options Held
1.05M-
Vanguard Group Inc Valley Forge, PA10.9MShares$118 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$104 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.12MShares$44.7 Million0.0% of portfolio
-
State Street Corp Boston, MA4.04MShares$43.9 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.68MShares$29.1 Million0.25% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $825M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...